CALCIMIP VETERINARY

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

BORIC ACID; CALCIUM GLUCONATE; MAGNESIUM CHLORIDE

Disponible desde:

MIP VETERINARIA LTD

Código ATC:

A12AA03

formulario farmacéutico:

SOLUTION FOR INFUSION

Composición:

BORIC ACID 60 MG/ML; CALCIUM GLUCONATE 240 MG/ML; MAGNESIUM CHLORIDE 60 MG/ML

Vía de administración:

I.V

tipo de receta:

Required

Fabricado por:

BELA-PHARM, GERMANY

Área terapéutica:

CALCIUM GLUCONATE

indicaciones terapéuticas:

For the treatment of hypocalcamia complicated by a deficiency of magnesium in cattle and sheep.

Fecha de autorización:

2020-03-31

Ficha técnica

1. NAME OF THE VETERINARY MEDICINAL PRODUCT:
CALCIMIP VETERINARY
2. QUALITATIVE AND QUANTITATIVE COMPOSITION :
100 ml solution for infusion contain:
_Pharmacological active substances:_
_ _
Calcium gluconate (Ph. Eur.)
24.0 g
(equivalent to Ca
2+
: 2.15 g or 54 mmol)
Magnesium chloride, 6 H
2
O
6.0 g
(equivalent to Mg
2+
: 0.72 g or 30 mmol)
Boric acid
6.0 g
For the full list of excipients, see section 6.1.
The solution does not contain any endotoxins.
Highly hypertonic solution.
3. PHARMACEUTICAL FORM:
Solution for slow intravenous infusion.
Clear, colourless to slightly yellowish solution for infusion.
4. CLINICAL PARTICULARS
4.1 TARGET ANIMAL SPECIES:
Cattle, Sheep.
4.2 AREAS OF APPLICATION:
Cattle, Sheep:
For the treatment of hypocalcamia complicated by a deficiency of
magnesium in cattle
and sheep
.
4.3 CONTRAINDICATIONS:
- hypercalcaemia and hypermagnesaemia,
- idiopathic hypocalcaemia in foals,
- calcinosis in cattle and small ruminants,
- septicaemic processes in the course of acute mastitis in cattle,
- application in the wake of high doses of vitamin D
3
preparations,
- chronic renal insufficiency,
- intravenous administration of inorganic phosphorous solutions at the
same time or
shortly thereafter.
4.4 SPECIAL WARNINGS FOR EACH TARGET ANIMAL SPECIES:
None known.
4.5 SPECIAL PRECAUTIONS FOR USE
_Special precautions for use in animals: _
Intravenous administration must be performed slowly.
During infusion, cardiac rate and rythm and circulation must be
controlled. If any signs
of
overdose
(disturbances
of
the
cardiac
rhythm
decrease
in
blood
pressure,
restlessness) appears, the infusion has to be stopped immediately.
_Special safety precautions to be taken by the person administering
the medicinal _
_product to animals _
None known.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
EVEN IF THE THERAPEUTIC DOSAGE IS CORRECT, TRANSIENT HYPERCALCAEMIA
CAN OCCUR
DUE TO THE CALCIUM CONCENTRATION. IT PRESENTS AS FOLLOWS:
- initial bradycardia,
- restlessness, muscle tremor, salivation,
- increased respiratory